Fermbox and Dyadic Launch 1st Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)

Our animal-origin free recombinant proteins and enzymes portfolio, developed with Dyadic, augments Fermbox’s strategy ...
Nature

Food Enzyme Safety and Allergenicity Evaluation

Food enzymes have long been integral to food processing, facilitating improvements in texture, flavour and nutritional quality, while contemporary research increasingly emphasises the need for ...

Industrial Enzymes Industry Competitive Landscape Report 2025: Top Companies Analysis, Profiles, Strategic Developments, Mergers, Sustainability Goals, Product Innovations and ...

The Industrial Enzymes market is poised for significant growth, projected to reach $12.05 billion by 2033 from $7.46 billion in 2025, with a CAGR of 6.18%. This industry plays a vital role in sectors ...

Dyadic International, Inc.: Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development ...

Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company producing ...
Phys.org

Engineered enzymes enable greener one-pot amide synthesis for drug manufacturing

A single type of chemical structure that shows up again and again in modern medicine is the amide bond that links a carbonyl group (C=O) to a nitrogen atom. They're so ubiquitous that 117 of the top ...
The Manila Times

Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)

Dyadic Applied BioSolutions ('Dyadic”, 'we”, 'us”, 'our”, or the 'Company”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life ...